CYTR Related Press Releases

May 20, 2013 08:30 AM CytRx Issues Letter to Stockholders Providing Business Update

May 9, 2013 08:30 AM CytRx Reports 2013 First Quarter Financial Results

May 8, 2013 08:30 AM CytRx Provides Update on Clinical Programs

May 6, 2013 08:30 AM CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma

Apr 23, 2013 08:30 AM CytRx Announces Agreement with FDA on Special Protocol Assessment for Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin for Soft Tissue Sarcoma